2018
DOI: 10.1016/j.healun.2017.12.008
|View full text |Cite
|
Sign up to set email alerts
|

Utility of troponin assays for exclusion of acute cellular rejection after heart transplantation: A systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
23
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(23 citation statements)
references
References 29 publications
0
23
0
Order By: Relevance
“…The most frequently used biomarkers in patients with heart transplantation are troponin and B-type natriuretic peptide (BNP). However, there is considerable heterogeneity among studies about the timing of their use and their predictive value for detecting ACR [15,16].Two-dimensional speckle-tracking echocardiography (STE) is an echocardiographic modality for the evaluation of myocardial deformation, enabling the determination of multiple parameters involved in cardiac mechanics, and it has emerged as a promising tool for detecting early subclinical cardiac dysfunction in many different scenarios [17,18]. Previous studies in the heart transplant population demonstrated that, in this setting, the data are not definitive, and further exploration of cardiac mechanics is necessary [19,20].…”
Section: Introductionmentioning
confidence: 99%
“…The most frequently used biomarkers in patients with heart transplantation are troponin and B-type natriuretic peptide (BNP). However, there is considerable heterogeneity among studies about the timing of their use and their predictive value for detecting ACR [15,16].Two-dimensional speckle-tracking echocardiography (STE) is an echocardiographic modality for the evaluation of myocardial deformation, enabling the determination of multiple parameters involved in cardiac mechanics, and it has emerged as a promising tool for detecting early subclinical cardiac dysfunction in many different scenarios [17,18]. Previous studies in the heart transplant population demonstrated that, in this setting, the data are not definitive, and further exploration of cardiac mechanics is necessary [19,20].…”
Section: Introductionmentioning
confidence: 99%
“…As acute rejection promotes cardiomyocyte necrosis and results in compromised cardiac mechanics, cardiac troponin and BNP have been evaluated as potential diagnostic tools for ACR (39,40). There have been controversial results on these biomarkers in the eld of heart transplantation (41,42). Our study used an ultrasensitive assay for cardiac troponin I that detects 10 to 100 times lower levels than standard assays.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, there has been much effort to develop noninvasive and accurate methods that can reduce the need for EMB, including biomarker detection, imaging techniques and genetic tests (13,14). The most used biomarkers in patients with heart transplantation are troponin and BNP, however there is a considerable heterogeneity among studies about the time dosage and the predict value for detect ACR (15,16).…”
Section: Introductionmentioning
confidence: 99%
“…Rates of significant ACR vary between 5% and 21% 36. Severe rejection can result in significant cardiac dysfunction, but many milder episodes are diagnosed on surveillance biopsies when patients have no or minimal symptoms and signs.…”
Section: Discussionmentioning
confidence: 99%